Imagine a hospital in the Czech Republic has tested a new digital solution. The technology works, delivers promising results, and its safety and usability have been positively evaluated. Can a Polish hospital use these findings to make a faster implementation decision? In theory, yes. In practice, however, the solution often has to undergo a very similar assessment process almost from scratch.
This is precisely the challenge that HealthBridge_CE aims to address. In this international project, seven institutions from six Central European countries are working together to develop a common approach to testing and evaluating innovative medical technologies. One of the partners is the Mother and Child Institute in Warsaw (IMiD), with its Implementation Department leading the project on behalf of the Institute. The initiative is closely aligned with the activities of the MCSC platform, which is why we strongly encourage you to learn more about this important project.
Goal: Making the Path of Innovation to Hospitals Easier
Medical technologies are evolving faster than the procedures that enable their adoption into everyday clinical practice. The challenge is often not the lack of effective solutions, but rather the way they are evaluated, the differences between healthcare systems, and the limited ability to leverage evidence generated in other countries.
HealthBridge_CE seeks to address these barriers by developing a common framework for the testing, validation, and assessment of digital health technologies. The project’s goal is to support hospitals and public institutions in making informed decisions about the adoption and scaling of innovative medical solutions.
Importantly, this does not mean replacing national requirements or streamlining procedures at the expense of patient safety. On the contrary, the project partners aim to create a model that allows reliable evidence generated in one country to be more effectively recognized and utilized by healthcare institutions across other countries, reducing duplication of effort while maintaining high standards of quality and safety.
Why Is It So Difficult to Transfer Medical Innovations Between Countries?
At first glance, a solution that has been tested in a hospital and received positive assessments for effectiveness, safety, and usability should have a clear path to wider adoption.
In reality, however, existing evidence is often not sufficient to support implementation decisions, especially in another country. Additional analyses may be required, documentation may need to be prepared according to different standards, and in some cases further testing is necessary.
Some of these requirements are entirely justified. Healthcare systems differ in their organization, reimbursement models, infrastructure, regulatory environments, and patient needs. A technology that performs well in one clinical setting may not automatically deliver the same results in another.
The challenge arises when there is no common framework for evaluation and when previously generated evidence cannot be easily compared, interpreted, or reused. As a result, hospitals incur additional costs and spend valuable time repeating similar assessment processes, while technology developers face further barriers to scaling and deploying their solutions.
HealthBridge_CE aims to streamline this process by creating a shared approach to the assessment and validation of digital health innovations, enabling hospitals and public authorities to make better use of trusted evidence generated across different countries while maintaining high standards of quality, safety, and patient care.
How Does HealthBridge_CE Work? From Common Standards to Real-World Hospital Testing
At the heart of the project is the development of the Integrated Living-Lab Operation Protocol (ILLOP), a shared framework for conducting pilot studies of innovative medical technologies.
Behind this technical name lies a practical tool designed to define how new solutions should be tested, what types of data should be collected, how outcomes should be evaluated, and how results should be documented so they can be understood, trusted, and reused beyond the country where the pilot is conducted.
A key role will be played by living labs: collaborative environments where innovative technologies are tested and refined together with their future users. In healthcare, this means the active involvement of hospitals, healthcare professionals, researchers, experts, patients, and technology developers throughout the evaluation process.
HealthBridge_CE will include pilot implementations of innovative digital health solutions in real clinical settings. These pilots will provide an opportunity to verify how the common assessment framework works in practice, rather than only on paper, and to identify any challenges that may arise during real-world deployment.
The project will also strengthen three cross-border cooperation areas: Czech Republic-Germany, Slovakia-Austria, and Czech Republic-Poland. These partnerships will help participating countries exchange experience, align methodologies, and build trust in evidence generated across different healthcare systems.
Another important component of HealthBridge_CE will be workshops and consultations involving representatives of organizations responsible for Health Technology Assessment (HTA) and healthcare financing. It is often at the intersection of clinical evidence, technology assessment, and reimbursement decisions that the future of an innovation is ultimately determined.
The project’s outcomes will include national implementation roadmaps for Poland, the Czech Republic, and Slovakia, as well as a joint strategy for long-term cross-border collaboration. This is also why the Polish Ministry of Health serves as an associated partner of the Mother and Child Institute (IMiD) within the project.
What Can Hospitals, Startups, and Patients Gain?
The benefits of HealthBridge_CE can be viewed from several perspectives.
For Hospitals
Common standards could provide easier access to structured and comparable evidence on emerging healthcare technologies. Rather than relying solely on manufacturers’ claims or organizing every stage of the evaluation process independently, hospitals may be able to make greater use of experience and data generated by other healthcare providers, including those in other countries. This could support more informed decision-making, reduce duplication of effort, and lower the resources required to assess innovative solutions before implementation.
For Startups and MedTech Companies
The development of shared evaluation standards offers the prospect of a more predictable pathway for technology development and validation. Clear validation criteria can help innovators design pilot projects more effectively and document outcomes in a manner that is meaningful not only for local stakeholders but also for potential international partners. In the long term, this may facilitate expansion beyond domestic markets, improve market access, and contribute to more equitable adoption of innovative healthcare solutions across Europe.
For Public Institutions
HealthBridge_CE may provide tools that support the assessment of the clinical, organizational, and economic value of new technologies. This is particularly important when decision-makers must determine not only whether a technology works, but also whether its broader adoption is justified from the perspectives of healthcare outcomes, resource utilization, and sustainability. Such evidence-based approaches can contribute to more transparent and effective decision-making processes.
For Patients
The most tangible potential benefit is faster access to technologies whose value has been reliably demonstrated. However, this should not be seen as an automatic outcome of the project. Access will continue to depend on national regulations, reimbursement decisions, procurement processes, and the capabilities of individual healthcare providers.
Nevertheless, the project partners expect that by reducing duplication and improving the transferability of evidence between countries, the pathway from validation to implementation can be shortened, ultimately increasing access to beneficial innovations for patients.
HealthBridge_CE will not eliminate all regulatory and organizational barriers to innovation. However, it has the potential to reduce unnecessary repetition of evaluation efforts and support implementation decisions based on more consistent, transparent, and comparable evidence across healthcare systems.
Who Is Behind HealthBridge_CE? Meet the Seven Project Partners
HealthBridge_CE is being delivered by a consortium of seven organizations from the Czech Republic, Germany, Slovenia, Slovakia, Austria, and Poland. Together, they bring expertise spanning innovation management, startup collaboration, scientific research, data analysis, healthcare policy, and direct patient care.
This diversity is intentional. Successfully implementing medical technologies requires far more than developing a promising solution. It demands clinical expertise, organizational know-how, robust evaluation methods, and a deep understanding of how healthcare systems operate in practice.
Each partner contributes a unique perspective to the project, helping ensure that the solutions developed within HealthBridge_CE are not only innovative, but also practical, scalable, and relevant to the needs of hospitals, policymakers, technology developers, and patients across Central Europe.
By combining knowledge from healthcare providers, research institutions, innovation hubs, and public-sector stakeholders, the consortium aims to build a framework that supports more effective testing, validation, and adoption of digital health technologies across national borders.
DEX Innovation Centre – Czech Republic | Project Lead

DEX Innovation Centre is a Czech organization dedicated to fostering innovation, entrepreneurship, and international collaboration. Operating at the intersection of technology, business, and the public sector, it supports the development and scaling of solutions that address real-world market and societal needs.
As the lead partner of HealthBridge_CE, DEX Innovation Centre is responsible for coordinating the international consortium and ensuring the successful delivery of the project’s shared objectives. Its extensive experience in building innovation ecosystems, facilitating cross-sector partnerships, and managing international initiatives provides a strong foundation for a project that depends on effective cooperation between organizations operating across different countries and healthcare systems.
Within HealthBridge_CE, DEX plays a central role in connecting stakeholders from healthcare, research, public administration, and industry, helping to create the conditions needed for the successful testing, validation, and adoption of innovative digital health technologies across Central Europe.
Carl Gustav Carus University Hospital in Dresden – Germany

The Carl Gustav Carus University Hospital, affiliated with the TU Dresden (Dresden University of Technology), combines clinical care, scientific research, and medical education within one of Germany’s leading academic healthcare institutions.
Organizations like university hospitals play a particularly important role in the development and evaluation of medical technologies. They provide an environment where innovative solutions can be tested against the real needs of healthcare professionals and patients, while also enabling rigorous assessment of their effectiveness, safety, and usability in everyday clinical practice.
The hospital’s participation in HealthBridge_CE strengthens the project’s clinical dimension and ensures that the perspectives of frontline healthcare providers are reflected throughout the development of common evaluation frameworks. Its experience in patient care, research, and innovation contributes valuable insight into the practical challenges associated with testing, validating, and implementing new technologies in healthcare settings.
By bridging scientific excellence and clinical reality, the Carl Gustav Carus University Hospital helps ensure that the project’s outcomes are not only methodologically robust but also relevant and applicable in real-world healthcare environments.
University of Ljubljana, Faculty of Social Sciences – Slovenia

The Faculty of Social Sciences at the University of Ljubljana brings expertise in social sciences, organizational research, and the analysis of societal and institutional change to the HealthBridge_CE consortium.
The successful adoption of healthcare innovation depends on much more than technical performance alone. Factors such as stakeholder engagement, communication, trust in new technologies, organizational culture, and the willingness of institutions to embrace change can significantly influence whether an innovation succeeds or fails in practice.
Within HealthBridge_CE, the Slovenian partner contributes valuable research and analytical capabilities that help examine how innovations are perceived, adopted, and integrated into healthcare systems. This perspective complements the consortium’s technological and clinical expertise, ensuring that the project addresses not only how digital health solutions should be evaluated, but also how they can be effectively implemented and accepted by healthcare professionals, decision-makers, and patients.
By incorporating organizational and social dimensions into the assessment process, the University of Ljubljana, Faculty of Social Sciences helps ensure that the project’s outcomes are both scientifically grounded and practical for real-world adoption across diverse healthcare environments.
Slovak Alliance for Innovation Economy (SAPIE) – Slovakia

The Slovak Alliance for Innovation Economy (SAPIE) is a Slovak organization dedicated to fostering an innovation-driven economy. It brings together entrepreneurs, startups, technology companies, investors, and other stakeholders within the innovation ecosystem, creating opportunities for collaboration and growth.
Within HealthBridge_CE, SAPIE contributes valuable expertise in building connections between innovators and the institutions that can support the development, validation, and adoption of new technologies. This experience is particularly important in healthcare, where successful innovation depends not only on technological excellence but also on effective cooperation between technology developers, healthcare providers, policymakers, and investors.
SAPIE brings a strong entrepreneurial and market-oriented perspective to the consortium. Its involvement helps ensure that the project’s outcomes are relevant not only for hospitals and public institutions, but also for startups and MedTech companies seeking clear and reliable pathways for testing, validating, and scaling digital health solutions.
By representing the needs and realities of the innovation ecosystem, SAPIE supports HealthBridge_CE’s ambition to create a framework that enables healthcare innovation to move more efficiently from development to real-world implementation, ultimately benefiting healthcare systems, technology providers, and patients alike.
Institute of Health Information and Statistics of the Czech Republic

The Czech Institute of Health Information and Statistics (ÚZIS) is the national institution responsible for collecting, analyzing, and disseminating healthcare data in the Czech Republic. Its work supports evidence-based decision-making across the healthcare system, providing insights into healthcare delivery, outcomes, and resource utilization.
Within HealthBridge_CE, expertise in health information management and data analytics is particularly important. Developing common validation frameworks requires not only agreement on what should be assessed, but also on how data should be collected, measured, analyzed, and interpreted to ensure that results are reliable and comparable across different healthcare settings.
The participation of ÚZIS brings a system-level perspective to the consortium, helping to ensure that evaluation methodologies are grounded in robust data practices and aligned with the needs of healthcare policymakers and decision-makers. Its expertise contributes to improving the quality, consistency, and interoperability of evidence generated through pilot projects and living labs.
By focusing on data quality, comparability, and the effective use of health information, ÚZIS helps HealthBridge_CE build a foundation for more transparent and evidence-based adoption of digital health innovations across Central Europe.
Geriatric Health Centres of the City of Graz – Austria

The Geriatric Health Centres of the City of Graz (GGZ) are an Austrian healthcare organization providing geriatric services and advancing research, education, and knowledge development in the field of ageing and elderly care. The organization participates in HealthBridge_CE together with the Albert Schweitzer Institute for Geriatrics and Gerontology, a recognized center of expertise in geriatric medicine and age-related healthcare.
This perspective is particularly relevant to HealthBridge_CE. As European populations continue to age, healthcare systems face growing challenges related to chronic diseases, long-term care, workforce capacity, and the coordination of complex care pathways. Digital health technologies have the potential to support these efforts by improving care delivery, enabling remote monitoring, enhancing communication between care providers, and helping healthcare professionals manage growing patient needs more effectively.
The participation of the Austrian partner ensures that the needs of geriatric and long-term care settings are considered when developing and validating new digital health solutions. Their practical experience contributes valuable insights into how technology can be applied to support older adults while maintaining quality of care, patient safety, and dignity.
By bringing expertise in ageing, gerontology, and long-term care, the Geriatric Health Centres of the City of Graz help ensure that the HealthBridge_CE framework addresses the realities of one of the most important and rapidly growing areas of healthcare across Europe.
Mother and Child Institute – Poland

The Mother and Child Institute (IMiD) in Warsaw is a leading clinical, scientific, and research institution that combines patient care with activities supporting the development and implementation of medical innovation.
HealthBridge_CE is being delivered on behalf of the Institute by the Implementation Department – Center for Innovation and Artificial Intelligence, a team dedicated to fostering collaboration between technology innovators, researchers, healthcare providers, and industry partners. Through initiatives such as the MCSC platform, the Institute has developed extensive experience in supporting the validation and adoption of innovative healthcare solutions in real clinical environments.
Within HealthBridge_CE, IMiD contributes to the development of the common framework for validating digital health technologies, participates in stakeholder engagement and workshop activities, and supports the preparation and execution of pilot projects in clinical settings. These activities help ensure that the project’s methodologies are both scientifically robust and practically applicable within healthcare organizations.
A particularly important component of the project is the Polish-Czech cooperation area, where partners will jointly test the proposed evaluation framework and exchange experience related to the implementation of healthcare innovation. This cross-border collaboration will help verify how common assessment methods perform in practice and how evidence generated in one country can support decision-making in another.
The Polish Ministry of Health participates in HealthBridge_CE as an associated partner of the Mother and Child Institute. Its involvement brings the perspective of public administration and the national healthcare system into the project, helping align the initiative with broader healthcare policy and innovation priorities.
For the Mother and Child Institute, participation in HealthBridge_CE is a natural extension of its existing mission: moving from connecting hospitals with technology developers to helping shape international frameworks that can improve how healthcare innovations are assessed, validated, and adopted across Europe. By contributing both clinical expertise and practical implementation experience, IMiD plays a key role in ensuring that the project’s outcomes support real-world innovation in healthcare.
From Individual Pilots to a Shared European Approach
HealthBridge_CE officially launched on 1 September 2026 and will run until 31 August 2028. The project’s total budget is approximately €1.24 million, with 80% co-financed by the European Regional Development Fund (ERDF) through the Interreg CENTRAL EUROPE 2021–2027 Programme.
Building on the experience and lessons learned from earlier Interreg initiatives, HealthBridge_CE aims to transform existing knowledge into practical tools and methodologies that can continue to support healthcare innovation long after the project has concluded. Rather than focusing solely on individual pilot projects, the consortium seeks to establish sustainable frameworks that facilitate the testing, validation, and adoption of digital health technologies across borders.
Ultimately, the success of HealthBridge_CE will be measured not by the number of reports produced, but by whether the developed standards prove useful in the day-to-day work of hospitals, innovation teams, healthcare authorities, and organizations responsible for evaluating and financing new technologies. If successful, the project could help reduce duplication of effort, improve the transferability of evidence, and support more informed decisions about healthcare innovation throughout Central Europe.
Further information about the project is available on the HealthBridge_CE project page within the Interreg CENTRAL EUROPE Programme and on the MCSC website.
HealthBridge_CE (CE0401380) is co-financed by the European Union under the Interreg CENTRAL EUROPE 2021–2027 Programme through the European Regional Development Fund (ERDF).Make it more conciseEmphas